Legal & General Group Portfolio holdings
Legal & General Group Plc, founded in 1836 by six lawyers in London, is a British multinational financial services company headquartered in London, renowned for its leadership in insurance, pensions, and investment management. Managing trillions in assets, the firm operates through key divisions like Legal & General Investment Management (LGIM), one of the UK’s largest asset managers, focusing on index funds, active strategies, and sustainable investing for institutional clients like pension funds. It also provides life insurance, retirement products, and general insurance, serving millions of customers with a strong emphasis on long-term financial security and infrastructure investment, such as affordable housing. With a heritage of stability and a modern push toward ESG (environmental, social, governance) principles, Legal & General remains a cornerstone of the UK financial landscape with a growing global presence.
Top Buys
| 1 |
NVIDIA
NVDA
|
$415M |
| 2 |
Tesla
TSLA
|
$360M |
| 3 |
Capital One
COF
|
$328M |
| 4 |
Johnson & Johnson
JNJ
|
$168M |
| 5 |
EMA
Emera Incorporated
EMA
|
$164M |
Top Sells
| 1 |
Microsoft
MSFT
|
$1.14B |
| 2 |
Apple
AAPL
|
$1.03B |
| 3 |
DFS
Discover Financial Services
DFS
|
$296M |
| 4 |
Eli Lilly
LLY
|
$215M |
| 5 |
Amazon
AMZN
|
$205M |
Sector Composition
| 1 | Technology | 34.3% |
| 2 | Financials | 13.54% |
| 3 | Consumer Discretionary | 9.84% |
| 4 | Healthcare | 9.2% |
| 5 | Communication Services | 8.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3001
Middlefield Banc Corp
MBCN
$235M
| $20.1K | ﹤0.01% |
669
+69
| +12% | +$2.08K |
|
3002
Palladyne AI
PDYN
$290M
| $20.1K | ﹤0.01% |
+2,324
| New | +$20.1K |
|
3003
Mayville Engineering Co
MEC
$305M
| $20.1K | ﹤0.01% |
1,260
| – | – |
|
3004
Astria Therapeutics
ATXS
$423M
| $20.1K | ﹤0.01% |
3,744
-27,674
| -88% | -$148K |
|
3005
Zumiez
ZUMZ
$364M
| $19.9K | ﹤0.01% |
1,503
| – | – |
|
|
HIMX
3006
Himax Technologies
HIMX
$1.47B
| $19.8K | ﹤0.01% |
2,214
| – | – |
|
3007
CuriosityStream
CURI
$264M
| $19.7K | ﹤0.01% |
+3,505
| New | +$19.7K |
|
3008
Radiant Logistics
RLGT
$304M
| $19.7K | ﹤0.01% |
3,235
| – | – |
|
3009
Erasca
ERAS
$437M
| $19.6K | ﹤0.01% |
15,428
-171,397
| -92% | -$218K |
|
3010
MaxCyte
MXCT
$150M
| $19.5K | ﹤0.01% |
8,963
-16,207
| -64% | -$35.3K |
|
3011
Pure Cycle
PCYO
$264M
| $19.5K | ﹤0.01% |
1,818
-262
| -13% | -$2.81K |
|
3012
Cardiff Oncology
CRDF
$147M
| $19.5K | ﹤0.01% |
6,185
+633
| +11% | +$1.99K |
|
3013
Forum Energy Technologies
FET
$310M
| $19.4K | ﹤0.01% |
998
| – | – |
|
|
CIO
3014
City Office REIT
CIO
$280M
| $19.4K | ﹤0.01% |
3,629
+358
| +11% | +$1.91K |
|
|
INZY
3015
DELISTED
Inozyme Pharma
INZY
| $19.3K | ﹤0.01% |
4,813
| – | – |
|
|
FVR
3016
FrontView REIT, Inc.
FVR
$274M
| $19.2K | ﹤0.01% |
1,604
+380
| +31% | +$4.56K |
|
3017
LCNB Corp
LCNB
$226M
| $19.2K | ﹤0.01% |
1,324
+337
| +34% | +$4.9K |
|
3018
Verastem
VSTM
$632M
| $19.2K | ﹤0.01% |
4,617
+401
| +10% | +$1.66K |
|
3019
Esperion Therapeutics
ESPR
$504M
| $19.2K | ﹤0.01% |
19,464
+1,923
| +11% | +$1.89K |
|
3020
Monte Rosa Therapeutics
GLUE
$296M
| $19.1K | ﹤0.01% |
4,245
+648
| +18% | +$2.92K |
|
3021
3D Systems Corporation
DDD
$277M
| $19.1K | ﹤0.01% |
12,426
+1,389
| +13% | +$2.14K |
|
3022
iHeartMedia
IHRT
$338M
| $19.1K | ﹤0.01% |
10,846
+1,958
| +22% | +$3.45K |
|
3023
Sight Sciences
SGHT
$193M
| $19K | ﹤0.01% |
4,605
+720
| +19% | +$2.97K |
|
3024
AMC Networks
AMCX
$342M
| $19K | ﹤0.01% |
3,031
| – | – |
|
3025
Biglari Holdings Class B
BH
$977M
| $19K | ﹤0.01% |
65
| – | – |
|